skip to content

Cambridge Stem Cell Institute

 
Read more at: Professor Walid Khaled awarded ERC Advanced Grant for breast cancer research
Image of someone receiving a shot in their arm; image of Professor Walid Khaled

Professor Walid Khaled awarded ERC Advanced Grant for breast cancer research

18 June 2025

Yesterday the European Research Council (ERC) announced the winners of its latest Advanced Grant competition. CSCI’s Professor Walid Khaled was selected as one of 281 leading researchers across Europe to receive some of the 721 million euros in funding to pursue his breast cancer research. The ERC fund will provide €2.5...


Read more at: Professor Zilbauer opens new Cambridge centre, aiming to transform physical and mental health of children with inflammatory bowel diseases
Matt Zilbauer at the launch of the event

Professor Zilbauer opens new Cambridge centre, aiming to transform physical and mental health of children with inflammatory bowel diseases

11 June 2025

This past weekend, Professor Matthias Zilbauer of CSCI launched the new Cambridge Centre for Children’s Gut Health, welcoming over 100 children living with inflammatory bowel diseases (IBD) such as Crohn’s disease and ulcerative colitis. Zilbauer, Professor of Paediatric Gastroenterology at the University of Cambridge and...


Read more at: CSCI & Department of Haematology scientists develop new treatment with potential to tackle common form of childhood cancer
Doctor and child

CSCI & Department of Haematology scientists develop new treatment with potential to tackle common form of childhood cancer

20 May 2025

Research out this week finds that a combination of two drugs could improve outcomes and reduce the need for toxic chemotherapy for B-cell acute lymphoblastic leukaemia (B-ALL), the most common cancer in childhood and one that can be particularly difficult to treat in older patients. In recent years, new treatments have...


Read more at: SCI-TIF community gathers for 3rd Annual Networking Dinner
SCI-TIF Event photo collage

SCI-TIF community gathers for 3rd Annual Networking Dinner

29 April 2025

Last week, the Cambridge Stem Cell Institute Technology & Innovation Forum (SCI-TIF) celebrated its 3rd Annual Networking Dinner at Homerton College, Cambridge. This event brought together leading scientists from academia and industry, reinforcing SCI-TIF’s mission to unite the Cambridge stem cell community and foster...


Read more at: Professor Sarah Teichmann announced as new member of the American Academy of Arts & Sciences
Teichmann announcement

Professor Sarah Teichmann announced as new member of the American Academy of Arts & Sciences

24 April 2025

Professor Sarah Teichmann FMedSci FRS, Chair in Stem Cell Medicine at the University of Cambridge (Cambridge Stem Cell Institute & Dept Medicine), and Group Leader at CSCI, has been announced this week as one of the newest members of the prestigious American Academy of Arts & Sciences . Sarah says, “ It is a...


Read more at: Groundbreaking discovery from Tzelepis Lab could revolutionise treatment for deadly blood cancers
acute myeloid leukaemia cells

Groundbreaking discovery from Tzelepis Lab could revolutionise treatment for deadly blood cancers

23 April 2025

A new study from Dr Konstantinos Tzelepis at the Cambridge Stem Cell Institute has discovered a new way to detect and target Acute Myeloid Leukaemia (AML), a fast growing, aggressive, blood cancer that requires urgent treatment. The research was published today (23 April) in Nature Biotechnology. AML is the second most...


Read more at: New research from Vassiliou Group shows diabetes drug may prevent aggressive leukaemia
Researchers in lab

New research from Vassiliou Group shows diabetes drug may prevent aggressive leukaemia

17 April 2025

Research out this week from the Vassiliou and Huntly Groups shows that a common diabetes drug could prevent a form of acute myeloid leukaemia in people at high risk of the disease. The research, published 16 April in Nature , found that metformin, a widely used and readily available diabetes drug, could prevent abnormal...


Read more at: Rapid growth of blood cancer driven by a single genetic 'hit' in new paper from Nangalia Group
Leukocyte smear

Rapid growth of blood cancer driven by a single genetic 'hit' in new paper from Nangalia Group

11 April 2025

Researchers have explored the evolution of the genetic change that causes chronic myeloid leukaemia and show its ability to drive the disease. A new study has unveiled when chronic myeloid leukaemia, a type of cancer that affects the blood and bone marrow, arises in life and how fast it grows. Researchers reveal explosive...


Read more at: Zilbauer Group and CSCI host Human Organoid Symposium
Organoid event

Zilbauer Group and CSCI host Human Organoid Symposium

4 April 2025

Last week (28 March), the Zilbauer Group and the Cambridge Stem Cell Institute Technology and Innovation Forum (SCI-TIF) hosted the 1st Cambridge Human Organoid Symposium at Jesus College, Cambridge. The event brought together a diverse group of scientists, clinicians, and industry leaders to delve into the latest...


Read more at: New insights into ageing revealed in recent study from Nangalia group and collaborators
Blood cells

New insights into ageing revealed in recent study from Nangalia group and collaborators

6 March 2025

Research has uncovered fundamental differences in how blood stem cells evolve with age in mice compared to humans, reshaping our understanding of ageing and disease. The way in which blood stem cells evolve over a lifespan differs greatly between humans and mice, new research reveals. The findings provide a new...